Effects of the SGLT2 Inhibition on Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats, a Model of Type 1 Diabetes Mellitus.
Camila Moreno RosaDijon Henrique Salome CamposDavid Rafael Abreu ReyesFelipe Cesar DamattoLucas Yamada KurosakiLuana Urbano PaganMariana Janini GomesCamila Renata CorrêaAna Angelica Henrique FernandesMarina Politi OkoshiKatashi OkoshiPublished in: Antioxidants (Basel, Switzerland) (2022)
Dapagliflozin is safe, increases body weight, decreases glycemia and oxidative stress, and attenuates cardiac remodeling in an experimental rat model of Type 1 diabetes mellitus.